We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$1.23B
AUM Growth
+$104M
Cap. Flow
+$31.1M
Cap. Flow %
2.53%
Top 10 Hldgs %
31.33%
Holding
580
New
21
Increased
213
Reduced
117
Closed
18

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$20M
2
META icon
Meta Platforms (Facebook)
META
+$11.2M
3
MASI
Masimo
MASI
+$9.79M
4
AMED
Amedisys
AMED
+$8.72M
5
LLY icon
Eli Lilly
LLY
+$3.19M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$18.5M
2
MRK icon
Merck
MRK
+$17.1M
3
BAC icon
Bank of America
BAC
+$11.1M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.63M
5
C icon
Citigroup
C
+$3.04M

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Financials 17.86%
3 Communication Services 15.58%
4 Consumer Discretionary 15.53%
5 Healthcare 12.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAS icon
326
Masco
MAS
$14.7B
$382K 0.03%
8,700
+1,600
+23% +$65K
WRK
327
DELISTED
WestRock Company
WRK
$382K 0.03%
6,039
ULTA icon
328
Ulta Beauty
ULTA
$23.6B
$380K 0.03%
1,700
+300
+21% +$63.5K
MXIM
329
DELISTED
Maxim Integrated Products
MXIM
$376K 0.03%
7,200
-1,700
-19% -$88.3K
IDXX icon
330
Idexx Laboratories
IDXX
$46.9B
$375K 0.03%
2,400
+400
+20% +$63K
CE icon
331
Celanese
CE
$4.88B
$375K 0.03%
3,500
DOV icon
332
Dover
DOV
$28.3B
$374K 0.03%
4,581
FRC
333
DELISTED
First Republic Bank
FRC
$373K 0.03%
4,300
+800
+23% +$75.8K
BR icon
334
Broadridge
BR
$19.8B
$371K 0.03%
4,100
EXPE icon
335
Expedia Group
EXPE
$37.7B
$371K 0.03%
3,100
LEA icon
336
Lear
LEA
$8.05B
$371K 0.03%
2,100
+400
+24% +$70.2K
EMN icon
337
Eastman Chemical
EMN
$8.39B
$371K 0.03%
4,000
+700
+21% +$63.6K
DAL icon
338
Delta Air Lines
DAL
$58.7B
$370K 0.03%
6,600
+900
+16% +$47K
KMX icon
339
CarMax
KMX
$8.34B
$366K 0.03%
5,700
CAG icon
340
Conagra Brands
CAG
$7.07B
$365K 0.03%
9,700
AKAM icon
341
Akamai
AKAM
$16.9B
$364K 0.03%
5,600
+900
+19% +$49.8K
RMD icon
342
ResMed
RMD
$31.9B
$364K 0.03%
4,300
+700
+19% +$57.8K
SLG icon
343
SL Green Realty
SLG
$3.9B
$363K 0.03%
3,719
+517
+16% +$50.3K
PKG icon
344
Packaging Corp of America
PKG
$22.7B
$362K 0.03%
3,000
BALL icon
345
Ball Corp
BALL
$16.6B
$360K 0.03%
9,500
+1,700
+22% +$69K
RSG icon
346
Republic Services
RSG
$65.7B
$358K 0.03%
5,300
KSU
347
DELISTED
Kansas City Southern
KSU
$358K 0.03%
3,400
BKR icon
348
Baker Hughes
BKR
$63.6B
$358K 0.03%
11,300
VOYA icon
349
Voya Financial
VOYA
$9.08B
$356K 0.03%
7,200
+900
+14% +$38.7K
ALLY icon
350
Ally Financial
ALLY
$13.3B
$356K 0.03%
12,200

Similar funds

E. Ohman J:or Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, E. Ohman J:or Asset Management held 580 positions worth $1.23B, up 9.2% from $1.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

E. Ohman J:or Asset Management's Q4 2017 filing shows 21 new, 213 increased, 117 reduced and 18 closed positions. Its largest new stake was Masimo: 112,885 shares worth $9.57M. The largest sale was PayPal, an estimated $18.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Communication Services.

  • E. Ohman J:or Asset Management's largest Q4 2017 buy was Masimo: 112,885 shares worth $9.57M.
  • E. Ohman J:or Asset Management added most to JPMorgan Chase in Q4 2017, an estimated $20M increase.
  • E. Ohman J:or Asset Management's biggest Q4 2017 reduction was PayPal, cutting an estimated $18.5M.
  • E. Ohman J:or Asset Management fully exited Teva Pharmaceuticals in Q4 2017, selling an estimated $3.63M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 31% of its $1.23B portfolio in Q4 2017.
  • E. Ohman J:or Asset Management opened 21 new positions and closed 18 in Q4 2017.
  • E. Ohman J:or Asset Management's portfolio value rose 9.2% quarter-over-quarter to $1.23B.

Based on E. Ohman J:or Asset Management's 13F filing for Q4 2017, filed 5 Apr 2024.